dextroamphetamine has been researched along with Glioblastoma in 1 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, CE | 1 |
| Aguilar, B | 1 |
| Starr, R | 1 |
| Yang, X | 1 |
| Chang, WC | 1 |
| Weng, L | 1 |
| Chang, B | 1 |
| Sarkissian, A | 1 |
| Brito, A | 1 |
| Sanchez, JF | 1 |
| Ostberg, JR | 1 |
| D'Apuzzo, M | 1 |
| Badie, B | 1 |
| Barish, ME | 1 |
| Forman, SJ | 1 |
1 other study available for dextroamphetamine and Glioblastoma
| Article | Year |
|---|---|
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma.
Topics: Animals; Antibodies, Neoplasm; Antigens, CD19; Brain Neoplasms; Cytotoxicity, Immunologic; Dextroamp | 2018 |